Guilin Sanjin Pharmaceutical Co.,Ltd.’s Net Profit Rose 25.3% in First Half of 2023

Guilin Sanjin Pharmaceutical Co.,Ltd. (桂林三金药业股份有限公司) (002275.SZ) reported a net profit of 379.5 million yuan in the first half of 2023, up 25.3% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, up 20% year-on-year.

At the end of the reporting period, it had 3.8 billion yuan in total assets and 810 million yuan in total liabilities, with a liability-to-asset ratio of 21.5%.